ANRO – alto neuroscience, inc. (US:NASDAQ)
Stock Stats
News
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
Alto Neuroscience (NYSE:ANRO) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $28.00 price target on the stock, up previously from $27.00.
Alto Neuroscience Announces Completion of Enrollment in Phase 2 Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia
Alto Neuroscience Highlights Invited Review in American Journal of Psychiatry Establishing Neuroplasticity as a Core Driver of Psychiatric Disease and Treatment [Yahoo! Finance]
Alto Neuroscience Highlights Invited Review in American Journal of Psychiatry Establishing Neuroplasticity as a Core Driver of Psychiatric Disease and Treatment
Form 4 Alto Neuroscience, Inc. For: Mar 01 Filed by: Etkin Amit
Form 4 Alto Neuroscience, Inc. For: Mar 01 Filed by: Smith Nicholas Conrad
Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: ARMISTICE CAPITAL, LLC
Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: ARMISTICE CAPITAL, LLC
Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: K2 HealthVentures Equity Trust LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.